Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Endothelin-axis antagonism enhances tumor perfusion in pancreatic cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Endothelin-axis antagonism enhances tumor perfusion in pancreatic cancer.
Endothelin-axis antagonism enhances tumor perfusion in pancreatic cancer. Cancer Lett. 2022 09 28; 544:215801.
View in:
PubMed
subject areas
Endothelin Receptor Antagonists
Endothelins
Humans
Pancreatic Neoplasms
Perfusion
Sulfonamides
Tumor Microenvironment
authors with profiles
Ravi Salgia